Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Irene, Galani"'
Autor:
Paraskevi C. Fragkou, Ignatios Ikonomidis, Dimitrios Benas, Dimitra Kavatha, Charalampos D. Moschopoulos, Konstantinos Protopapas, Gavriella Kostelli, John Thymis, Dionysia Mpirmpa, Irene Galani, Maria Tsakona, Chrysanthi Oikonomopoulou, George Theocharous, Vassilis G. Gorgoulis, Parisis Gallos, Sotirios Tsiodras, Anastasia Antoniadou, Antonios Papadopoulos, Helen Triantafyllidi
Publikováno v:
Viruses, Vol 15, Iss 7, p 1505 (2023)
Endothelial glycocalyx (EG) derangement has been associated with cardiovascular disease (CVD). Studies on EG integrity among people living with HIV (PLWH), are lacking. We conducted a prospective cohort study among treatment-naïve PLWH who received
Externí odkaz:
https://doaj.org/article/a53ebc8d64f541b3aa9d4136b25cdd77
Autor:
Vassiliki Papoutsaki, Irene Galani, Eleni Papadimitriou, Irene Karantani, Ilias Karaiskos, Helen Giamarellou
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 20, Iss , Pp 98-104 (2020)
Objectives: Treatment of infections caused by carbapenemase-producing Klebsiella pneumoniae (CPKP) frequently involves combination therapy with various antimicrobial agents in the hope of achieving synergistic effects. Routine laboratory antimicrobia
Externí odkaz:
https://doaj.org/article/ae417e3d558546f497aed91e15652e30
Autor:
Irene Galani, Konstantina Nafplioti, Panagiota Adamou, Ilias Karaiskos, Helen Giamarellou, Maria Souli, Study Collaborators
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background To evaluate the in vitro activities of plazomicin and comparator aminoglycosides and elucidate the underlying aminoglycoside resistance mechanisms among carbapenemase-producing K. pneumoniae isolates collected during a nationwide
Externí odkaz:
https://doaj.org/article/ea643aabb3024c80a2e8a2860dee1d83
Autor:
Triantafyllidi, Paraskevi C. Fragkou, Ignatios Ikonomidis, Dimitrios Benas, Dimitra Kavatha, Charalampos D. Moschopoulos, Konstantinos Protopapas, Gavriella Kostelli, John Thymis, Dionysia Mpirmpa, Irene Galani, Maria Tsakona, Chrysanthi Oikonomopoulou, George Theocharous, Vassilis G. Gorgoulis, Parisis Gallos, Sotirios Tsiodras, Anastasia Antoniadou, Antonios Papadopoulos, Helen
Publikováno v:
Viruses; Volume 15; Issue 7; Pages: 1505
Endothelial glycocalyx (EG) derangement has been associated with cardiovascular disease (CVD). Studies on EG integrity among people living with HIV (PLWH), are lacking. We conducted a prospective cohort study among treatment-naïve PLWH who received
Autor:
Irene, Galani, Georgios, Priniotakis, Ioannis, Chronis, Anastasios, Tzerachoglou, Diamantis, Plachouras, Marianthi, Chatzikonstantinou, Philippe, Westbroek, Maria, Souli
Publikováno v:
In Diagnostic Microbiology & Infectious Disease June 2016 85(2):205-209
Autor:
Irene Galani, Vassiliki Papoutsaki, Ilias Karaiskos, Nikolaos Moustakas, Lamprini Galani, Sofia Maraki, Viktoria Eirini Mavromanolaki, Olga Legga, Kimon Fountoulis, Evangelia D. Platsouka, Panagiota Giannopoulou, Helen Papadogeorgaki, Maria Damala, Efrosini Chinou, Aggeliki Pasxali, Ioannis Deliolanis, Helen Vagiakou, Efthymia Petinaki, Anastasia Chli, Eleni Vagdatli, Polyzo Kazila, Vassiliki Papaioannou, Konstantina Kontopoulou, Atalia Noemi Ferke, Eleni Moraitou, Anastasia Antoniadou, Helen Giamarellou
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases.
Resistance of Acinetobacter baumannii to multiple clinically important antimicrobials has increased to very high rates in Greece, rendering most of them obsolete. The aim of this study was to determine the molecular epidemiology and susceptibilities
Publikováno v:
Expert Review of Anti-infective Therapy. 20:53-69
Introduction: The emergence of carbapenemase resistant Gram-negative is designated as an ‘urgent’ priority of public health. Carbapenemase producing Klebsiella pneumoniae (CPKP) is linked with sign...
Publikováno v:
Expert Review of Anti-infective Therapy. 19:1457-1468
Introduction: Multi-drug-resistant Klebsiella pneumoniae is currently one of the most pressing emerging issues in bacterial resistance. Treatment of K.pneumoniae infections is often problematic due to the lack of available therapeutic options, with a
Autor:
Irene Galani, Konstantina Nafplioti, Panagiota Adamou, Ilias Karaiskos, Helen Giamarellou, Maria Souli, Study Collaborators
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-1 (2019)
Following publication of the original article [1],
Externí odkaz:
https://doaj.org/article/2cb2b2bacb62479a84a16b737134602e
Autor:
Ilias Karaiskos, E Papadimitriou, Aggelos Stefos, A Masgala, Garyphallia Poulakou, Christina Routsi, Georgios Chrysos, Kostoula Arvaniti, Karolina Akinosoglou, Irene Galani, G Adamis, E Filiou, Georgios Daikos, E Mouloudi, Dimitrios Basoulis, S Symbardi, Hellenic Ceftazidime, Lamprini Galani, Aikaterini Gkoufa, M Petraki, Helen Giamarellou
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:775-783
Background Infections caused by KPC-producing Klebsiella pneumoniae (Kp) are associated with high mortality. Therefore, new treatment options are urgently required. Objectives To assess the outcomes and predictors of mortality in patients with KPC- o